IDH1-MUTANT GLIOMA

Clinical trials for IDH1-MUTANT GLIOMA explained in plain language.

Never miss a new study

Get alerted when new IDH1-MUTANT GLIOMA trials appear

Sign up with your email to follow new studies for IDH1-MUTANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Promising combo tackles brain tumors in early trial

Disease control Ongoing

This study tests a new drug combination (vorasidenib plus temozolomide) in people with a specific type of brain tumor called IDH-mutant glioma. The goal is to find the safest dose and see if it helps control the tumor. About 51 participants aged 12 and older will take part, with …

Matched conditions: IDH1-MUTANT GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

IDH1-MUTANT GLIOMA

Get alerted when new IDH1-MUTANT GLIOMA trials appear

Promising combo tackles brain tumors in early trial